• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2020 October 16

Post Archive by Day

International validation of the Bullous Pemphigoid Disease Area Index (BPDAI) severity score and calculation of cut-off values for defining mild, moderate and severe type of bullous pemphigoid.

In Dermatology
by ClinOwl
October 16, 2020

The Bullous-Pemphigoid-Disease-Area-Index (BPDAI) score has been proposed to provide an objective measure of bullous pemphigoid (BP) activity.To calculate BPDAI cut-off values defining mild, moderate and severe BP, and to assess …

The climate emergency: why should dermatologists care, and how can they act?

In Dermatology
by ClinOwl
October 16, 2020

Weather and climate exist on a massive scale: over the last 650,000 years, only seven glacial cycles have occurred. The end of the last ice age 12,000 years ago marked …

View Post

Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer

In HealthDay News
by Healthday
October 16, 2020

Risk higher in first five years of follow-up for those treated with breast-conserving surgery alone

View Post

UEG: Allergy-Related Dz Tied to Irritable Bowel Syndrome at 16

In HealthDay News
by Healthday
October 16, 2020

Asthma and food hypersensitivity at age 12 years associated with increased risk for IBS at age 16 years

View Post

UEG: Pancreatic CA Down With Bariatric Sx for Obese With DM

In HealthDay News
by Healthday
October 16, 2020

Prevalence of pancreatic cancer higher in patients with predisposing diabetes and obesity without BS

View Post

Upadacitinib Tops Abatacept for RA Refractory to DMARDs

In HealthDay News
by Healthday
October 16, 2020

Superior for mean change in composite DAS28-CRP values and remission, but more adverse events seen

View Post

Negative D-Dimer Can Safely Rule Out DVT as Standalone Test

In HealthDay News
by Healthday
October 16, 2020

Standalone D-dimer testing followed by whole-leg compression US in positive patients rules out DVT

View Post

Pharmacotherapy, Psychotherapy Combo Best for Bipolar Disorder

In HealthDay News
by Healthday
October 16, 2020

Manualized treatments linked to significantly reduced recurrence rates versus control treatments

View Post

Outcomes Worse for Women With MI at 50 Years or Younger

In HealthDay News
by Healthday
October 16, 2020

Women less likely to undergo coronary revascularization, receive guideline-directed medical treatment

View Post

Reinfection With SARS-CoV-2 Described in 25-Year-Old

In HealthDay News
by Healthday
October 16, 2020

Patient had two positive tests in April and June 2020, separated by two negative tests in May 2020

  • Page 1 of 2
  • 1
  • 2
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

October 2020
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep   Nov »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer